US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
(Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 151.91%83.54K | 213.35%36.02K | -96.01%-158.27K | -160.93%-385.35K | -332.89%-111.87K | -221.11%-160.95K | -31.65%-31.78K | -69.71%-80.75K | 75.98%-147.68K | 60.89%-25.84K |
Net income from continuing operations | 161.47%27.87K | 22.19%-64.75K | 28.17%-95.27K | 16.76%-399.77K | 3.41%-194.59K | 111.25%10.66K | -71.10%-83.21K | 2.09%-132.63K | 55.89%-480.28K | 49.91%-201.45K |
Operating gains losses | ---- | ---- | ---- | -400.98%-525K | 55.01%-8.21K | ---509.53K | ---22 | ---7.24K | ---104.8K | ---18.25K |
Depreciation and amortization | 119.86%63.27K | --63.02K | --61.58K | 1,189.32%106.94K | 3,337.03%78.16K | 5,011.55%28.78K | --0 | --0 | -49.19%8.29K | -29.92%2.27K |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 155.26%129.48K | ---- |
Remuneration paid in stock | -97.81%8.89K | --11.05K | --0 | 756.58%406.62K | --0 | 5,079.70%404.85K | --0 | -88.56%1.77K | -76.27%47.47K | -83.60%4.17K |
Other non cashItems | --9.06K | --11.8K | --12.58K | --21.27K | --12.76K | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 75.49%-25.54K | -71.03%14.91K | -339.13%-137.16K | -98.17%4.61K | -99.99%7 | -387.66%-104.21K | -41.76%51.45K | -17.65%57.36K | 56.69%252.15K | -72.51%57.93K |
-Change in receivables | 69.96%-48.65K | -340.62%-8.87K | -806.47%-34.73K | -3,851.05%-199.63K | -6,811.63%-37.52K | -2,951.95%-161.97K | -65.73%3.69K | -460.91%-3.83K | 104.89%5.32K | 100.41%559 |
-Change in prepaid assets | 107.24%849 | 114.90%1.49K | 251.42%1.5K | -8,900.00%-4.77K | 185.32%17.94K | -285.02%-11.73K | -975.11%-9.99K | 92.85%-988 | -100.72%-53 | 50.20%6.29K |
-Change in payables and accrued expense | -67.97%22.25K | -61.41%22.28K | -267.16%-103.93K | -15.34%209.01K | -61.65%19.59K | 97.45%69.49K | -24.46%57.75K | -26.11%62.18K | -5.93%246.88K | -85.03%51.09K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 151.91%83.54K | 213.35%36.02K | -96.01%-158.27K | -160.93%-385.35K | -332.89%-111.87K | -221.11%-160.95K | -31.65%-31.78K | -69.71%-80.75K | 75.98%-147.68K | 60.89%-25.84K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 101.83%17.23K | -341,481.82%-75.1K | -431.60%-24.02K | -10,658.24%-947.71K | -275.53%-14.64K | -148,417.19%-940.33K | 22 | 7.24K | 8.98K | 8.34K |
Net PPE purchase and sale | --0 | -52,654.55%-11.56K | --0 | -76.47%2.11K | -99.70%25 | -916.88%-5.18K | --22 | --7.24K | --8.98K | --8.34K |
Net other investing changes | --17.23K | ---63.54K | ---24.02K | ---949.82K | ---964.49K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 101.83%17.23K | -341,481.82%-75.1K | -431.60%-24.02K | -10,658.24%-947.71K | -275.53%-14.64K | -148,417.19%-940.33K | --22 | --7.24K | --8.98K | --8.34K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -105.23%-79.29K | -156.96%-99.71K | -101.55%-1.17K | 1,038.74%1.76M | -126.75%-2.4K | 3,598.99%1.51M | 289.73%175.05K | 25.90%75.54K | -75.19%154.84K | -64.72%8.96K |
Net issuance payments of debt | 64.46%-79.29K | -597.93%-124.71K | -101.55%-1.17K | -171.44%-124.91K | -126.75%-2.4K | -644.72%-223.1K | -44.24%25.05K | -5.57%75.54K | 283.16%174.84K | -64.72%8.96K |
Net common stock issuance | ---- | ---- | ---- | --2M | --0 | ---- | ---- | ---- | --0 | --0 |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | -459.52%-111.9K | --0 | ---261.9K | ---- | ---- | 56.57%-20K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -105.23%-79.29K | -156.96%-99.71K | -101.55%-1.17K | 1,038.74%1.76M | -126.75%-2.4K | 3,598.99%1.51M | 289.73%175.05K | 25.90%75.54K | -75.19%154.84K | -64.72%8.96K |
Net cash flow | ||||||||||
Beginning cash position | -35.90%98.53K | 2,157.99%235.08K | 4,900.29%418.52K | 207.87%8.37K | 3,301.81%575.14K | 504.16%153.7K | 123.22%10.41K | 207.87%8.37K | 54.11%-7.76K | -66.07%16.91K |
Current changes in cash | -94.81%21.48K | -196.86%-138.79K | -9,088.93%-183.46K | 2,566.83%430.13K | -1,409.99%-128.91K | 4,948.38%413.71K | 589.68%143.29K | -83.57%2.04K | 76.27%16.13K | 79.01%-8.54K |
Effect of exchange rate changes | -161.83%-4.78K | --2.24K | --19 | ---19.98K | ---27.71K | --7.73K | --0 | --0 | --0 | --0 |
End cash Position | -79.97%115.23K | -35.90%98.53K | 2,157.99%235.08K | 4,900.29%418.52K | 4,900.29%418.52K | 3,301.81%575.14K | 504.16%153.7K | 123.22%10.41K | 207.87%8.37K | 207.87%8.37K |
Free cash from | 150.30%83.54K | 176.97%24.46K | -96.01%-158.27K | -164.41%-390.49K | -332.89%-111.87K | -231.37%-166.1K | -31.65%-31.78K | -69.71%-80.75K | 75.98%-147.68K | 60.89%-25.84K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.